Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types | JCO Precision Oncology
PURPOSEPD-1 inhibition is effective in patients with mismatch repair deficient (dMMR) solid tumors in a tumor-agnostic fashion. However, dMMR testing by immunohistochemistry (IHC) is not routinely performed across tumor types. By contrast, next-generation …